C. Pelloski

发表

Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.

Se Hoon Kim, K. Aldape, D. Cahill, 2013, Cancer cell.

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

R. Wilson, C. Perou, K. Aldape, 2010, Cancer cell.

FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

Raymond Sawaya, Suyun Huang, K. Aldape, 2006, Cancer research.

A multigene predictor of outcome in glioblastoma.

K. Aldape, M. Gilbert, M. Mehta, 2010, Neuro-oncology.

Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma

Li Zhang, Susan Chang, Howard Colman, 2006, Clinical Cancer Research.

CT-based volumetric dosimetry of intracavitary brachytherapy for cervical cancer

C. Pelloski, G. Chronowski, J. Horton, 2003 .

Multimodality treatment of osteosarcoma: Radiation in a high‐risk cohort

C. Pelloski, C. Herzog, A. Mahajan, 2008, Pediatric blood & cancer.

The application of radiation therapy to the pediatric preclinical testing program (PPTP): Results of a pilot study in rhabdomyosarcoma

P. Houghton, C. Pelloski, R. Kaplon, 2013, Pediatric blood & cancer.

Using NanoDot dosimetry to study the RS 2000 X-ray Biological Irradiator

C. Pelloski, N. Gupta, Lanchun Lu, 2013, International journal of radiation biology.

Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice.

E. Chiocca, C. Pelloski, C. Cook, 2012, Cancer research.

Cytomegalovirus Infection Leads to Pleomorphic Rhabdomyosarcomas in Trp53 þ / (cid:2) Mice

C. Pelloski, E. Chiocca, C. Cook, 2012 .

YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma

K. Aldape, M. Gilbert, H. Colman, 2005, Clinical Cancer Research.

A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.

L. Court, F. Mourtada, C. Pelloski, 2005, International journal of radiation oncology, biology, physics.

Elevated Phospho-S6 Expression Is Associated with Metastasis in Adenocarcinoma of the Lung

K. Aldape, Menghong Sun, I. Wistuba, 2008, Clinical Cancer Research.

Assessment and Prognostic Significance of Mitotic Index Using the Mitosis Marker Phospho-histone H3 in Low and Intermediate-grade Infiltrating Astrocytomas

Caterina Giannini, Kenneth Hess, Howard Colman, 2006, The American journal of surgical pathology.

Diagnostic and prognostic molecular markers in common adult gliomas

C. Pelloski, Andreana L. Rivera, 2010, Expert review of molecular diagnostics.

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers

C. Pelloski, 2012 .

Prognostic and predictive markers in glioma and other neuroepithelial tumors.

K. Aldape, C. Pelloski, E. Sulman, 2008, Current problems in cancer.

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.

Li Zhang, Howard Colman, Dima Suki, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selective repression of YKL‐40 by NF‐κB in glioma cell lines involves recruitment of histone deacetylase‐1 and ‐2

K. Aldape, M. Rehli, K. Bhat, 2008, FEBS letters.

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.

Howard Colman, B Nebiyou Bekele, Mark R Gilbert, 2010, Neuro-oncology.

Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.

P. Houghton, C. Pelloski, Changxian Shen, 2013, Cancer research.

Regulation of FANCD 2 by the mTOR Pathway Contributes to theResistanceofCancerCells toDNADouble-StrandBreaks

P. Houghton, C. Pelloski, Changxian Shen, 2013 .

2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double strand breaks

P. Houghton, C. Pelloski, Changxian Shen, 2013 .

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.

C. Pelloski, J. Cox, F. Cabanillas, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Management of complex breast cysts.

L. Venta, C. Pelloski, M. Morrow, 1999, AJR. American journal of roentgenology.

Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.

Patricia J Eifel, Anuja Jhingran, C. Pelloski, 2005, International journal of radiation oncology, biology, physics.

Erratum: MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma (Neuro-Oncology (2010) 12:2 (116-121))

Mark R. Gilbert, Howard Colman, K. Aldape, 2010 .

Her2-enriched breast cancer brain metastases exhibit resistance to Gamma Knife radiosurgery: findings from a single institutional series review

N. Mayr, C. Pelloski, J. Radawski, 2012, Journal of Radiation Oncology.

Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications.

G. Rao, C. Pelloski, F. Lang, 2009, Journal of neurosurgery.

A Clinical Dosimetry Analysis of Total Body Irradiation for Leukemia Patients

Y. Rong, M. Welliver, C. Pelloski, 2014 .

Optimal treatment planning for skull base chordoma: photons, protons, or a combination of both?

Xiaodong Zhang, C. Pelloski, A. Mahajan, 2007, International journal of radiation oncology, biology, physics.

Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice.

E. Chiocca, C. Pelloski, C. Cook, 2012, Cancer research.

Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.

P. Houghton, C. Pelloski, Changxian Shen, 2013, Cancer research.